Searched for: in-biosketch:true
person:husais06
Non calcium phosphate binders - Is there any evidence of benefit
Jadav, Paresh R; Husain, S Ali; Mohan, Sumit; Crew, Russell
PURPOSE OF REVIEW:Low-level evidence and opinion-based clinical practice guidelines highlight the substantial uncertainty in the practice patterns of hyperphosphatemia management in patients with chronic kidney disease (CKD). This manuscript reviews the evidence for the choice of phosphate binders and its impact on clinical outcomes. RECENT FINDINGS:Phosphate binders are among the most common medications prescribed for patients on dialysis. Clinical practice guidelines recommend lowering phosphate levels toward normal range and restricting calcium-based binders in all CKD patients. There is substantial gap in the evidence underlying these recommendations with lack of any placebo-controlled, randomized trials showing survival benefits for any class of phosphate-binders. Despite the lack of evidence for specific phosphate target or if lowering phosphate improves survival, use of phosphate binders has remained central strategy in approach to hyperphosphatemia. Use of binders has added to the cost and contributed significant pill burden. Restriction of calcium-based binders to avoid positive calcium balance and consequent vascular calcification risk has a physiological rationale and weight of observational studies. SUMMARY:There is currently no conclusive evidence that definitively guides the choice of any specific binders for management of hyperphosphatemia in patients with CKD. Use of noncalcium-based binders has a theoretical advantage in restricting total calcium intake to decrease the risk of vascular calcification but no proven benefits for mortality.
PMID: 35266882
ISSN: 1473-6543
CID: 5867702
Healthcare students support opt-out organ donation for practical and moral reasons
Qian, Long; Li, Miah T; King, Kristen L; Husain, Syed Ali; Cohen, David J; Mohan, Sumit
BACKGROUND AND PURPOSE:Changes to deceased organ donation policy in the USA, including opt-out and priority systems, have been proposed to increase registration and donation rates. To study attitudes towards such policies, we surveyed healthcare students to assess support for opt-out and priority systems and reasons for support or opposition. METHODS:We investigated associations with supporting opt-out, including organ donation knowledge, altruism, trust in the healthcare system, prioritising autonomy and participants' evaluation of the moral severity of incorrectly assuming consent in opt-in systems ('opt-in error') or opt-out systems ('opt-out error'), by conducting an online survey among healthcare students at a large academic institution. RESULTS:Of 523 respondents, 86% supported opt-out, including 53% who strongly supported the policy. The most popular reason for supporting opt-out was the potential for increased donation rates, followed by convenience for those not registered but willing to donate. The most popular reason for opposing opt-out was the belief that presuming consent is morally wrong. Those strongly supporting opt-out viewed the opt-in error as more morally unacceptable, and had higher knowledge and altruism scores. Those opposing opt-out viewed the opt-out error as more unacceptable, and had higher autonomy scores. 48% of respondents supported priority within opt-in systems; 31% supported priority in opt-out. CONCLUSIONS:There is strong support for opt-out organ donation among healthcare students, influenced by both practical and moral considerations.
PMCID:8651801
PMID: 34103365
ISSN: 1473-4257
CID: 5867532
Boosters and optimizing SARS-CoV-2 vaccine for transplantation: No time to wait [Comment]
Husain, Syed Ali; Argyropoulos, Christos P
PMID: 34370901
ISSN: 1600-6143
CID: 5867582
Long-Term Survival after Kidney Transplantation [Comment]
Husain, S Ali
PMID: 35108481
ISSN: 1533-4406
CID: 5867672
Variations in Deceased Donor Terminal Creatinine Values Reported in the OPTN Data Registry [Letter]
Yu, Kathleen; King, Kristen; Husain, Syed Ali; Mohan, Sumit
PMCID:8993485
PMID: 35197257
ISSN: 1555-905x
CID: 5867682
A case of belatacept-induced chilblain lupus [Case Report]
Kinariwalla, Neha; Tarazi, Meera; Lewin, Jesse M; Husain, Sameera; Husain, Syed A; Gallitano, Stephanie M
PMCID:8850551
PMID: 35198715
ISSN: 2352-5126
CID: 5867692
Impact of Extending Eligibility for Reinstatement of Waiting Time After Early Allograft Failure: A Decision Analysis
Husain, S Ali; King, Kristen L; Adler, Joel T; Mohan, Sumit; Perotte, Rimma
RATIONALE & OBJECTIVE/OBJECTIVE:The shortage of deceased donor kidneys identified for potential transplantation in the United States is exacerbated by a high proportion of deceased donor kidneys being discarded after procurement. We estimated the impact of a policy proposal aiming to increase organ utilization by extending eligibility for waiting time reinstatement for recipients experiencing early allograft failure after transplantation. STUDY DESIGN/METHODS:Decision analysis informed by clinical registry data. SETTING & POPULATION/METHODS:We used Organ Procurement and Transplantation Network data to identify 76,044 deceased-donor kidneys procured in the United States from 2013 to 2017, 80% of which were transplanted and 20% discarded. INTERVENTION/METHODS:Extend waiting time reinstatement for recipients experiencing allograft failure from the current 90 days to 1 year after transplantation. OUTCOME/RESULTS:Net impact to the waitlist, defined as the estimated number of additional transplants minus estimated increase in waiting list reinstatements. MODEL, PERSPECTIVE, & TIMEFRAME/METHODS:We estimated (1) the number of additional deceased donor kidneys that would be transplanted if there was a 5%-25% relative reduction in discards, and (2) the number of recipients who would regain waiting time under a 6-, 12-, 18-, and 24-month reinstatement policy. RESULTS:Reinstating a waiting time for recipients experiencing allograft failure up to 1 year after transplantation yielded more additional transplants than growth in additions to the waiting list for all model assumptions except the combination of a very low relative reduction in discards (5%) and a very high failure rate of transplanted kidneys that would previously have been discarded (≥5 times the rate of currently transplanted kidneys). LIMITATIONS/CONCLUSIONS:Lack of empirical evidence supporting the proposed impact of such a policy change. CONCLUSIONS:A policy change reinstating waiting time for deceased donor kidneys recipients with allograft failure up to 1 year after transplantation should explored as a decision science-based intervention to improve organ utilization.
PMID: 34562524
ISSN: 1523-6838
CID: 5867612
Reproducibility of Chronic Changes on High-Quality Deceased Donor Kidney Allograft Biopsies
Verduzco, Hector Alvarado; Batal, Ibrahim; Mohan, Sumit; Husain, S Ali
PMCID:9039481
PMID: 35497801
ISSN: 2468-0249
CID: 5867752
Impact of education on APOL1 testing attitudes among prospective living kidney donors
Nestor, Jordan G; Li, Amber J; King, Kristen L; Husain, S Ali; McIntosh, Tristan J; Sawinski, Deirdre; Iltis, Ana S; Goodman, Melody S; Walsh, Heidi A; DuBois, James M; Mohan, Sumit
It is unknown how providing prospective living donors with information about APOL1, including the benefits and drawbacks of testing, influences their desire for testing. In this study, we surveyed 102 participants with self-reported African ancestry and positive family history of kidney disease, recruited from our nephrology waiting room. We assessed views on APOL1 testing before and after presentation of a set of potential benefits and drawbacks of testing and quantified the self-reported level of influence individual benefits and drawbacks had on participants' desire for testing in the proposed context of living donation. The majority of participants (92%) were aware of organ donation and more than half (56%) had considered living donation. And though we found no significant change in response following presentation of the potential benefits and the drawbacks of APOL1 testing by study end significance, across all participants, "becoming aware of the potential risk of kidney disease among your immediate family" was the benefit with the highest mean influence (3.3±1.4), while the drawback with the highest mean influence (2.9±1.5) was "some transplant centers may not allow you to donate to a loved one". This study provides insights into the priorities of prospective living donors and suggests concern for how the information affects family members may strongly influence desires for testing. It also highlights the need for greater community engagement to gain a deeper understanding of the priorities that influence decision making on APOL1 testing.
PMCID:9113661
PMID: 34661305
ISSN: 1399-0012
CID: 5867632
Improving the Utilization of Deceased Donor Kidneys by Prioritizing Patient Preferences [Comment]
Mohan, Sumit; Husain, S Ali
PMID: 35985701
ISSN: 1555-905x
CID: 5867812